Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

Similar documents
The Bioresorbable Vascular Stent Dr Albert Ko

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

Cilostazol versus Clopidogrel after Coronary Stenting

The Cardiac Society of Australia and New Zealand

Ostial LAD: Single stent approach is the best. Antonio A. Pocoví, MD, FSCAI, MTSAC, Advisory Council Member, CACI

LEADERS: 5-Year Follow-up

Experience of Direct Coronary Stenting at National Institute of Cardiovascular Diseases

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

Coronary Bifurcation Treatment: Update from the European Bifurcation Club. Remo Albiero, MD Ist. Clinico S. Rocco Brescia (Italy)

Listen to your heart: Good Cardiovascular Health for Life

PCI vs. CABG for Left Main Disease

MEDICAL POLICY No R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

OCT STEMI: OCT guidance during stent implantation

Antonio Colombo MD on behalf of the SECURITY Investigators

CARDIAC CARE. Giving you every advantage

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

California Health and Safety Code, Section

Clinical Research Intracoronary Stenting with Crushing in Coronary Artery Bifurcation Lesions: Initial Results and Medium-Term Follow Up

OPINION OPtical frequency domain imaging vs. INtravascular ultrasound in percutaneous coronary InterventiON

06 Validation of risk prediction model

Cardiovascular disease has become a dominant cause of

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

12 Lead ECGs: Ischemia, Injury & Infarction Part 2

Prognostic impact of uric acid in patients with stable coronary artery disease

The Minvasys Amazonia Pax & Nile Pax Polymer Free Paclitaxel Eluting Stent Program

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Coding Updates for 2013: Cardiology

Duration of Dual Antiplatelet Therapy After Coronary Stenting

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

Perioperative Cardiac Evaluation

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Drug-Eluting Balloons. Klaus Bonaventura Department of Cardiology and Angiology Heart Thorax Vascular Center, Klinikum Ernst von Bergmann, Potsdam

Repeat Coronary Revascularization Procedures after Successful Bare-Metal or Drug-Eluting Stent Implantation

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Majestic Trial 12 Month Results

Heart Center Packages

Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial

Cardiac Rehab. Home. Do you suffer from a cardiac condition that is limiting your independence in household mobility?

Main Effect of Screening for Coronary Artery Disease Using CT

The left internal mammary artery (LIMA) is the

Early And Late Outcome For Single Versus Double Stenting For Bifurcational Coronary Artery Lesions

URN: Family name: Given name(s): Address:

Do método diagnóstico ao terapêutico: a História da Hemodinâmica e da Cardiologia Intervencionista, em 15 minutos. Eulógio E Martinez

Cardiac Rehabilitation: Strategies Approaching 2020

2015 European Coronary Stent New Product Innovation Award

PIHRATE Trial. Polish-Italian-Hungarian Randomized ThrombEctomy Trial. Dariusz Dudek MD, PhD. On behalf PIHRATE investigators

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach

INNOVATIONS IN THE ENVIRONMENT: HOW THE HYBRID OPERATING ROOM CAN INFLUENCE CARDIAC SURGERY

Clinical Programs. Medtronic Coronary Stent Systems. driver BMS

έΰζβν αππ έκυ,νσϊίία κν1γν πλδζέκυνβί1γ π ηία δεόμνκαλ δκζόΰκμ, θν δ υγυθ άμνγνκαλ /εάμ ΚζδθδεάμΝ υλωεζδθδεάμν

Déjeuner/Repas Débat ABBOTT «Docteur, je veux un stent qui se dissout» ABSORB,la oui, mais chez quel Les dernières données ABSORB

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

FFR CT : Clinical studies

Preoperative Cardiac Stents Perioperative Management. Mark A. Taylor, MD Department of Anesthesia

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Same-Day PCI: Guidelines & Best Practices for In-N-Out Procedures

Diagnostic and Therapeutic Procedures

Cardiac Catheterization

GUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA - A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES -

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

Efficient Evaluation of Chest Pain

StentViz Enhanced Stent Visualization

Scott Hubbell, MHSc, RRT-NPS, C-NPT, CCT Clinical Education Coordinator/Flight RRT EagleMed

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

Credentials for Peripheral Angioplasty: Comments on Society of Cardiac Angiography and Intervention Revisions

INTERVENTION IN OSTIAL CORONARY LESIONS:

Measuring ROI Based on Procedure and Reimbursement Rate

NOVOSTE BETA-CATH SYSTEM

GENERAL HEART DISEASE KNOW THE FACTS

How To Determine Pad

SUTTER MEDICAL CENTER, SACRAMENTO Department of Cardiovascular Disease Cardiology - Delineation of Privileges

Intracoronary Stenting and. Robert A. Byrne, Julinda Mehilli, Salvatore Cassese, Franz-Josef Neumann, Susanne Pinieck, Tomohisa Tada,

Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care

Substandard Underwriting Structured Settlements

Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold Components

Clinical Training for Visage 7 Cardiac. Visage 7

Renal artery stenting: are there any indications left?

Cardiac Catheterization: Successful Coding and Chargemaster Practices

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Bayfront. Heart Center.

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to Reference Code: GDMECR0061PDB. Publication Date: May 2014

NCD for Lipids Testing

Presenter: Marco Valgimigli, MD PhD, FESC Erasmus MC, Thoraxcenter Rotterdam The Netherlands

Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC

Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options. A Guide for Patients

ST. DAVID S MEDICAL CENTER CARDIOLOGY - Special, Invasive, Diagnostic, or High-Risk Procedure Requirements

Q1: Global risk assessment using PROCAM, SCORE, FRAMINGHAM or REYNOLDS ecc is sufficient YES NO NEED MORE DATA DISCUSS within Taskforce Your Comments

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

Overview. Total Joint Replacement in the U.S. KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery?

Non Invasive Testing for CAD

Transcription:

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? --- NIRS-IVUS TVC Imaging Adds Additional Information for the Heart Team Dr. Luis Tami Memorial Regional Hospital Hollywood, FL

Patient History 64 year old female with unstable angina. Severe COPD requiring home oxygen for 2 years, obesity, hypertension, peripheral vascular disease, dyslipidemia and diabetes.

Angiographic Findings Total occlusion of the RCA with L to L collaterals filling PDA. An anomalous LCX is occluded and fills with L to L collaterals. Moderate stenosis by angiography is present in the left main. Ventriculogram shows inferior hypokinesis with EF 25%.

IVUS Imaging Results The L Main lesion observed on angiogram is shown by IVUS to cause significant narrowing with a minimal lumen area of 3.9 mm 2. Hence, this unstable angina patient has critical L main stenosis, plus an occluded RCA and LCX. The stenotic L main provides the almost all flow to the heart. Revascularization with CABG or stenting is required.

What is the Best Mode of Revascularization for this Patient? For CABG: Very high Syntax score, indicating high risk PCI. Good distal vessels for surgical bypass. Prevention of future coronary events by distal bypass insertion. Diabetic The risk of L Main PCI is increased by occluded RCA. Stenting L main only will not provide complete revascularization. For PCI: A L main stent could provide immediate relief for unstable angina and protect essential coronary flow. Very high STS score due to COPD requiring home oxygen, PVD, obesity, indicating high surgical risk. Recovery from PCI more rapid than recovery from CABG. Patient, family and cardiac surgeons prefer the stenting option.

The Potential Benefit of Determining the Amount of Coronary Lipid in a Patient with Extensive Disease Visible on Angiography Disparity Between Angiographic Coronary Lesion Complexity and Lipid Core Plaques Assessed by Near-Infrared Spectroscopy Zynda,Thompson, Khiet, Hoang, Seto, Glovaci, Wong, Patel, and Kern,CCI, 2013 In 78 patients, Lipid Core Burden Index was only weakly correlated with angiographic Syntax score. In the present case could there be extensive lipid that might complicate stenting and elevate risk beyond that indicated by the Syntax score which is based on angiographic findings?

NIRS Imaging Provides Additional Information The stenotic lesion in the L main also contains a large, circumferential LCP which extends into the ostium of the LAD. MaxLCBI4mm: 705 MLA: 3.9mm2 PB: 65% Left Main

The L Main Lipid Also Extends into the LAD, thus Involving the Bifurcation with the LCX LCX LAD

Extensive Lipid-rich Plaque (LRP) has Been Shown to Increased Short and Long-term Complications of Stenting While the risk/benefit ratio for stenting flow-limiting lesions is generally positive, stenting a site with increased LRP is associated with -- No-reflow and peri-stenting MI Goldstein et al., Circ Cardiovascular Interventions 2011 Brilakis et al, CCI, 2012 Stone et al, CANARY, TCT 2014 Early stent thrombosis. Sakhuja et al, Circulation 2010 Plaque shift into side branches. Husaini et al, CCI B-070, 2014 Stent failure post PCI. Dohi et al, JACC TCT-583, 2013

Stent Failure Post Placement Over a Stenotic Lesion with Elevated Max LCBI 4mm Similar to that of the Present Case Pre Stenting Index PCI Post Stenting In-stent Restenosis after 8 months Stent Segment DES 3.0x15mm Pre PCI NIRS findings MaxLCBI4mm in stent segment: 936 Dohi et al, JACC TCT-583, 2013

Excellent Outcome in a Prior Case in Which a Stent was Placed for a Stenotic Lesion with Minimal LRP Pre Stenting Post Stenting Stent segment Xience 2.5x23mm Xience 2.5x23mm Xience 2.5x15mm Pre PCI NIRS findings MaxLCBI4mm in stent segment: 157 Dohi et al, JACC TCT-583, 2013

Increased maxlcbi 4mm in the Stented Segment Grouped by Occurrence of Stent Failure 478 stented patients with a DES - mean FU = 392 days. 13 cases of stent failure. 1000 800 MaxLCBI 4mm Current Case = 705 P=0.043 The Max LCBI 4mm at baseline was significantly greater in those with stent failure. DES failure was not seen if Max LCBI <100. MaxLCBI 4mm 600 400 200 416 284 The current case has extensive LRP at the potential stenting site. 0 Stent Failure Non-Stent Failure N = 13 N = 30 Dohi et al, JACC TCT-583, 2013

In the Current Case the Max 4mm LCBI in the Target Lesion in the L Main was 705

Clinical Plan, and Outcome The NIRS finding of lipid in the L main was an additional piece of data in favor of CABG. A NIRS finding that the L main did not contain lipid would have been data in favor of PCI. Assessing the balance of findings for PCI or CABG, the interventional cardiologist recommended CABG. The recommendation for CABG and the supporting evidence, including the chemogram, were presented to the patient, family and surgeons. CABG was selected by consensus. A LIMA was placed to the LAD, SV to PDA and SV to the anomalous LCX. The ejection fraction increased from 25 to 35% and the patient is doing well 1 month post surgery. NIRS IVUS TVC imaging provided useful information for the heart team in deciding between PCI and CABG.